Inovio Pharmaceuticals Inc (NAS:INO)
$ 11.11 -0.89 (-7.42%) Market Cap: 287.87 Mil Enterprise Value: 218.74 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 48/100

Inovio Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 30, 2021 / 04:40PM GMT
Release Date Price: $85.92 (-1.51%)
Charles Duncan
Cantor Fitzgerald - Analyst

Hello. Welcome to the Cantor Global Healthcare Conference for 2021. My name is Charles Duncan. I'm a managing director and senior biotechnology analyst with the firm. And today is day four of the conference, and it's been quite a conference. And it's been quite a year, actually, for us and many, many folks since we last hosted our clients in the fall of 2020. And so it's a pleasure to introduce the next presenting company, that being Inovio Pharmaceuticals. And with me today, I have the pleasure to introduce the Company's CEO, Dr. Joseph Kim. Joe, how are you doing?

Joseph Kim
Inovio Pharmaceuticals, Inc. - President, CEO & Director

Hi, Charles. Great to be here. I'm doing great, thank you.

Questions & Answers

Charles Duncan
Cantor Fitzgerald - Analyst

Yes. Good. Greetings to you. And yes, it's been quite a year. Wow, lots of -- well, lots of challenge for a lot of people, for sure. But then also some real interesting innovation that has been positive to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot